home
companies
disclaimer
med safety app
COPALIA®
Film-coated Tablet
scheduling status
S3
registration number
45/7.1.3/0850; 45/7.1.3/0851; 45/7.1.3/1013; 45/7.1.3/1014
What COPALIA® contains
COPALIA 5/160 mg: Each film-coated tablet contains 6,94 mg amlodipine besylate (equivalent to 5 mg amlodipine base) and 160 mg valsartan. COPALIA 10/160 mg: Each film-coated tablet contains 13,87 mg amlodipine besylate (equivalent to 10 mg amlodipine base) and 160 mg valsartan. COPALIA 5/320 mg: Each film-coated tablet contains 6,94 mg amlodipine besylate (equivalent to 5 mg amlodipine base) and 320 mg valsartan. COPALIA 10/320 mg: Each film-coated tablet contains 13,87 mg amlodipine besylate (equivalent to 10 mg amlodipine base) and 320 mg valsartan.
other ingredients
COPALIA 5/160 mg film-coated tablets - Tablet core: Microcrystalline cellulose; Crospovidone; Colloidal silicon dioxide, anhydrous; Magnesium stearate. Coating: Hypromellose; Polyethylene glycol 4000; Talc; Titanium dioxide (E171); Iron oxide, yellow (E172). COPALIA 10/160 mg - Tablet core: Microcrystalline cellulos; Crospovidone; Colloidal silicon dioxide, anhydrous; Magnesium stearate. Coating: Hypromellose; Polyethylene glycol 4000; Talc; Titanium dioxide (E171); Iron oxide, yellow (E172); Iron oxide, red (E172 ). COPALIA 5/320 mg - Tablet core: Microcrystalline cellulose; Sodium starch glycolate; Crospovidone; Colloidal silicon dioxide, anhydrous; Magnesium stearate. Coating: Hypromellose; Polyethylene glycol 4000; Talc; Titanium dioxide (E171); Iron oxide, yellow (E172); Iron oxide, red (E172). COPALIA 10/320 mg - Tablet core: Microcrystalline cellulose; Sodium starch glycolate; Crospovidone; Colloidal silicon dioxide, anhydrous; Magnesium stearate. Coating: Hypromellose; Polyethylene glycol 4000; Tal.
Therapeutic classification
A 7.1.3 Vascular medicines – other hypotensives.
Download Patient Info Leaflet
Download Professional Info
© 2026 SAHPRA. ALL RIGHTS RESERVED